Laufey T. Ámundadóttir

National Institutes of Health

Full Professor(heuristic)

Pancreatic and Hepatic Oncology Research · Oncology

h-index54

i10-index101

Publications421

Citations13,842

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 94

Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8
eLife · 2026-05-06
Reviewer #1 (Public review): Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8
2026-05-06
Reviewer #2 (Public review): Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8
2026-05-06
Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8
eLife · 2026-05-06
Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals
medRxiv · 2026-04-22
Characterization of a pancreatic cancer GWAS signal suggests PDX1 buffers stress in the exocrine pancreas
medRxiv · 2026-04-15
Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus
medRxiv · 2026-03-04
Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near <i>CASP8</i>
bioRxiv (Cold Spring Harbor Laboratory) · 2026-01-06
3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility
Genome biology · 2025-12-08 · 1 citations
Supplementary Table 3 from Relationship between <i>ABO</i> Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (<i>FUT2</i>) Genotype, but Not Lewis Antigen (<i>FUT3</i>) Genotype
2025-11-26
Supplementary Table S3 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table 6 from Relationship between <i>ABO</i> Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (<i>FUT2</i>) Genotype, but Not Lewis Antigen (<i>FUT3</i>) Genotype
2025-11-26
Supplementary Table S7 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table 4 from Relationship between <i>ABO</i> Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (<i>FUT2</i>) Genotype, but Not Lewis Antigen (<i>FUT3</i>) Genotype
2025-11-26
Supplementary Table 2 from Relationship between <i>ABO</i> Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (<i>FUT2</i>) Genotype, but Not Lewis Antigen (<i>FUT3</i>) Genotype
2025-11-26
Supplementary Table S8 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Figure S2 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table S4 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table S6 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table S1 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26

Open author page on OpenAlex →